MAGE-6 (293-301)

MAGE-6 (293-301) is a synthetic peptide fragment derived from the melanoma-associated antigen 6 (MAGE-6) protein, spanning amino acid residues 293 to 301. As a member of the MAGE family, this peptide is notable for its role in tumor antigenicity and its restricted expression pattern, predominantly in various malignancies and certain reproductive tissues. The sequence represents a well-characterized epitope frequently investigated in immunological and oncological studies, making it a valuable tool for research into tumor immunology, antigen processing, and peptide-based functional assays. Its defined structure and immunogenic potential have positioned MAGE-6 (293-301) as a critical reagent in studies seeking to elucidate mechanisms of antigen recognition and immune modulation at the molecular level.

Epitope mapping: MAGE-6 (293-301) is widely employed in epitope mapping experiments to delineate the precise regions of the MAGE-6 protein that are recognized by T cells or antibodies. By incorporating this peptide into binding assays or cellular activation protocols, researchers can identify and characterize the immunodominant determinants within the MAGE-6 antigen. Such studies contribute to a deeper understanding of antigen-specific immune responses and support the identification of minimal recognition motifs essential for T-cell receptor engagement.

Immunogenicity assessment: The peptide serves as a model antigen for evaluating T-cell responses in vitro, especially in the context of tumor immunology. Utilizing MAGE-6 (293-301) in functional assays, such as ELISPOT or intracellular cytokine staining, allows investigators to quantify antigen-specific cytotoxic T lymphocyte (CTL) activity. These applications are critical for assessing the immunogenic potential of candidate epitopes and for monitoring immune reactivity in experimental systems, providing insight into the mechanisms underlying immune surveillance and tolerance.

Peptide-MHC binding studies: MAGE-6 (293-301) is frequently utilized in major histocompatibility complex (MHC) binding assays to investigate peptide affinity and stability within the context of antigen presentation. By analyzing its interaction with specific MHC class I alleles, researchers can elucidate the structural requirements for effective peptide loading and presentation to T cells. Such studies are fundamental for advancing knowledge of antigen processing pathways and for the rational design of peptide-based immunological probes.

Synthetic peptide controls: As a chemically defined peptide, MAGE-6 (293-301) is often used as a positive or negative control in a variety of immunological and biochemical assays. Its inclusion in experimental workflows enables the validation of assay sensitivity, specificity, and reproducibility, particularly in the context of peptide screening or immune monitoring platforms. The use of well-characterized synthetic peptides as controls is essential for ensuring the reliability and interpretability of experimental results in both basic and translational research settings.

Structural and functional studies: The defined sequence of MAGE-6 (293-301) provides an ideal template for probing the structural determinants of peptide recognition by immune receptors or for investigating peptide-protein interactions at the molecular level. Researchers employ this peptide in crystallography, NMR spectroscopy, or computational modeling to gain insight into the conformational dynamics and binding interfaces relevant to antigen recognition. These approaches facilitate a mechanistic understanding of immune specificity and inform the development of novel peptide-based research tools.

1. Cationic cell-penetrating peptides are potent furin inhibitors

2. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum

3. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review

4. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

5. Effect of Short-Term Desiccation, Recovery Time, and CAPA-PVK Neuropeptide on the Immune System of the Burying Beetle Nicrophorus vespilloides